Litigation Details for Teva Pharmaceuticals USA, Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2017)
✉ Email this page to a colleague
Teva Pharmaceuticals USA, Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-03-09 |
Court | District Court, D. Delaware | Date Terminated | 2017-12-10 |
Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
Jury Demand | None | Referred To | |
Patents | 9,402,874 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Teva Pharmaceuticals USA, Inc. v. Mylan Pharmaceuticals Inc.
Details for Teva Pharmaceuticals USA, Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-03-09 | 52 | -of-treatment patent covering the product, U.S. Patent No. 9,402,874 (“the ‘874 patent”) (D. Del., Civ…prior to the expiration of U.S. Patent No. 9,155,775 (“the ‘775 patent”), which Teva claims is infringed… The United States Patent and Trademark Office issued the ‘775 patent to Teva Ltd. on October 13…infringing the ‘775 patent. Id. It contends that the processes of the ‘775 patent “are the only commercially… the ‘775 patent in the District of Delaware before Teva filed its suit on the ‘775 patent against them | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |